We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Lannett Cuts Deal With Celgene In Thalomid Antitrust Case

Law360, San Diego (December 7, 2011, 2:47 PM EST) -- Lannett Co. Inc. on Tuesday resolved its antitrust suit in Pennsylvania federal court alleging Celgene Corp. unfairly blocked it from launching a generic version of Celgene’s thalidomide-based cancer drug Thalomid....
To view the full article, register now.




Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only


Pennsylvania Eastern

Nature of Suit



Subscribers Only

Date Filed

August 15, 2008

Law Firms


Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.